Watertown, MA · Founded 2021 · Privately Held (backing)
Developer of T cell-based immunotherapies intended to support cancer treatment. AvenCell is based in Watertown, MA and was founded in 2021. Its last reported valuation was $227 million in Oct 2024. It has raised $192 million.
Last reported valuation
$227.0M
Oct 2026
Priced at
—
Total raised
$192.4M
Last round
—
Team — not yet on record
No current team members for AvenCell are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AvenCell with a free account
·Watch AvenCell: the Monday email on marks, rounds and moves
